BCL2L11 and carcinoma: The expression of BCL2L11 protein showed clear decrease in GC, which is reduced by nearly 70% of that in para-carcinoma tissues (Fig. 1A and 1B); however, its mRNA levels did not differ significantly between the cancer and noncancerous tissues (Fig. 1C).